Platinib launch time

Pralsetinib is a highly potent, oral, selective RET inhibitor indicated for the treatment of certain types of non-small cell lung cancer (NSCLC) and certain thyroid cancers in adults. Platinib The U.S. Food and Drug Administration (FDA) approved marketing, and Platinib was launched in China in March 2022.

The usual dose for adults with non-small cell lung cancer is 400mg orally once daily for duration of treatment, with treatment continued until disease progression or unacceptable toxicity. The usual dose for adults with thyroid cancer is 400 mg orally once daily, with treatment duration until disease progression or unacceptable toxicity. The usual pediatric dose for thyroid cancer is 400 mg orally once daily for 12 years of age or older, with treatment duration until disease progression or unacceptable toxicity.

Platinib may cause swelling of the lungs (pneumonia) or interstitial lung disease. These are life-threatening conditions that require immediate medical attention. These symptoms may be similar to those of lung cancer. If you develop a new or worsening cough, fever, or difficulty breathing, consult your doctor immediately. Consult your doctor immediately if you develop blurred vision, dizziness, nervousness, headache, ringing in the ears, or a fast or slow heartbeat during or after treatment with this medication; these may be symptoms of high blood pressure. If you developupper abdominal pain or tenderness, lighter stools, darker urine, loss of appetite, nausea, vomiting, unusual fatigue or weakness, or yellowing of the eyes or skin, consult your doctor immediately as these may be symptoms of serious liver problems. This medicine can cause serious bleeding problems that may be life-threatening. Consult your doctor right away if you cough up blood, have heavy menstrual or vaginal bleeding, nosebleeds, red or black, tarry stools, red or dark brown urine, vomit blood or a substance that looks like coffee grounds, or any unusual bleeding or bruising. This drug may cause a serious reaction called tumor lysis syndrome. Your doctor may prescribe some medications to help prevent this. If you develop decreased or changed urine output, joint pain, stiffness, or swelling, lower back, side, or stomach pain, rapid weight gain, swelling of your feet or lower legs, unusual tiredness, or weakness, contact your doctor immediately. This medicine may affect the healing of wounds in the body. Ensure treatment Inform doctors who are using this medicine and patients This medication needs to be stopped a few days before and after surgery. If you plan to have children, talk to your doctor before using this drug. Some men and women who use this drug have become infertile (Infertile). This medicine also has an overseas version. The retail price of Lucius Pharmaceuticals in Laos is more than 1,000 yuan. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.